Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta‐analysis

By  

DIABETIC MEDICINE, Vol. 32, Iss. 12, 2015-12 ,pp. : 1530-1540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

By Raz Itamar   Chen Yu   Wu Mei   Hussain Shehla   Kaufman Keith D.   Amatruda John M.   Langdon Ronald B.   Stein Peter P.   Alba Maria  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 537-550

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study

By Williams-Herman Debora   Johnson Jeremy   Teng Rujun   Luo Edmund   Davies Michael J.   Kaufman Keith D.   Goldstein Barry J.   Amatruda John M.  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 569-583

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial

By Zeng Zhengpei  

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 921-929

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 11, 2015-11 ,pp. : 1056-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite